Atherogenics Inc Sample Contracts

AutoNDA by SimpleDocs
EXHIBIT 10.24 ATHEROGENICS, INC. 4-1/2% CONVERTIBLE NOTES DUE 2008 PURCHASE AGREEMENT August 13, 2003
Atherogenics Inc • November 14th, 2003 • Pharmaceutical preparations • New York
AMONG
Registration Rights Agreement • October 31st, 2003 • Atherogenics Inc • Pharmaceutical preparations • New York
COMMON STOCK
Underwriting Agreement • August 4th, 2000 • Atherogenics Inc • Pharmaceutical preparations • California
COMMON STOCK (NO PAR VALUE)
Underwriting Agreement • January 29th, 2003 • Atherogenics Inc • Pharmaceutical preparations • New York
To The Bank of New York Trust Company of Florida N.A., as Trustee INDENTURE Dated as of
Indenture • October 31st, 2003 • Atherogenics Inc • Pharmaceutical preparations • New York
WITNESSETH:
Employment Agreement • March 23rd, 2001 • Atherogenics Inc • Pharmaceutical preparations • Georgia
BETWEEN
License Agreement • July 13th, 2000 • Atherogenics Inc • Pharmaceutical preparations • Georgia
1 EXHIBIT 10.01 EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN ATHEROGENICS, INC.
Exclusive License Agreement • August 4th, 2000 • Atherogenics Inc • Pharmaceutical preparations • New Jersey
REGISTRATION RIGHTS AGREEMENT among ATHEROGENICS, INC. as Issuer, and MORGAN STANLEY & CO. INCORPORATED, LEHMAN BROTHERS INC. LAZARD FRÈRES & CO. LLC as Initial Purchasers Dated as of January 12, 2005
Registration Rights Agreement • January 13th, 2005 • Atherogenics Inc • Pharmaceutical preparations • New York

REGISTRATION RIGHTS AGREEMENT dated as of January 12, 2005 between AtheroGenics, Inc., a Georgia corporation (the “Company”), and Morgan Stanley & Co. Incorporated, Lehman Brothers Inc., J.P. Morgan Securities Inc. and Lazard Frères & Co. LLC (the “Initial Purchasers”) pursuant to the Purchase Agreement dated January 6, 2005 (the “Purchase Agreement”) between the Company and the Initial Purchasers. In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement.

EXHIBIT 10.20(b) EQUIPMENT TERM NOTE
Atherogenics Inc • May 13th, 2002 • Pharmaceutical preparations
WITNESSETH:
Patent Purchase Agreement • July 13th, 2000 • Atherogenics Inc • Pharmaceutical preparations • Georgia
AutoNDA by SimpleDocs
AND
Co-Promotion Agreement • March 10th, 2006 • Atherogenics Inc • Pharmaceutical preparations • New York
1 EXHIBIT 10.12 LEASE AGREEMENT COUSINS PROPERTIES INCORPORATED, a Georgia corporation, LANDLORD
Lease Agreement • February 25th, 2000 • Atherogenics Inc • Georgia
EMPLOYMENT AGREEMENT
Employment Agreement • September 29th, 2006 • Atherogenics Inc • Pharmaceutical preparations • Georgia

THIS AGREEMENT ("Agreement"), dated September 25, 2006 (the "Effective Date"), is made and entered into by and between AtheroGenics, Inc., a Georgia corporation (hereinafter called the "Employer"), and W. Charles Montgomery, Ph.D., a resident of the State of Georgia (hereinafter the "Executive").

INDEMNIFICATION AGREEMENT
Indemnification Agreement • July 6th, 2006 • Atherogenics Inc • Pharmaceutical preparations • Georgia

THIS AGREEMENT (the “Agreement”) is made and entered into as of this ____ day of __________, 2006, by and between ATHEROGENICS, INC., a Georgia corporation (the “Company”), and ________________________ (“Indemnitee”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in Section 16.

AMENDED EMPLOYMENT AGREEMENT
Amended Employment Agreement • March 3rd, 2008 • Atherogenics Inc • Pharmaceutical preparations • Georgia

THIS AGREEMENT (“Agreement”) amends and restates the Employment Agreement dated September 25, 2006 (the “Effective Date”), as amended, and is made and entered into by and between AtheroGenics, Inc., a Georgia corporation (hereinafter called the “Employer”), and Mark P. Colonnese, a resident of the State of Georgia (hereinafter the “Executive”).

EXHIBIT 10.21 PROMISSORY NOTE AND STOCK PLEDGE AGREEMENT
Note and Stock Pledge Agreement • August 13th, 2002 • Atherogenics Inc • Pharmaceutical preparations • Georgia
EXHIBIT 10.02 [ATHEROGENICS, INC. LOGO] 2004 EQUITY OWNERSHIP PLAN EQUITY OWNERSHIP AGREEMENT
Equity Ownership Agreement • March 10th, 2006 • Atherogenics Inc • Pharmaceutical preparations
First Amendment to the License Agreement Between Emory University and AtheroGenics
License Agreement • November 2nd, 2005 • Atherogenics Inc • Pharmaceutical preparations

This First Amendment (the “First Amendment”) having an effective date of August 3, 2005 amends the License Agreement between Emory University (“Emory”) and AtheroGenics Inc. (“AtheroGenics”) with an effective date of January 11, 1995, attached hereto as Attachment 1.

ASSET PURCHASE AGREEMENT BY AND BETWEEN CRABTREE ACQUISITION CO, LLC, ATHEROGENICS, INC. AND KING & SPALDING LLP MARCH 17, 2009
Asset Purchase Agreement • March 18th, 2009 • Atherogenics Inc • Pharmaceutical preparations • Georgia

THIS ASSET PURCHASE AGREEMENT dated as of March 16, 2009 (this “Agreement”) is entered into by and between Crabtree Acquisition Co, LLC, a Delaware limited liability company (“Purchaser”), AtheroGenics, Inc., a Georgia corporation (“Seller”), and solely for the purposes of Section 2.7, King & Spalding LLP, a Georgia limited liability partnership (“Seller's Counsel”). Purchaser and Seller are sometimes individually referred to in this Agreement as a “Party” and collectively as the “Parties.”

AGREEMENT
Master Rights Agreement • February 25th, 2000 • Atherogenics Inc • Georgia
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!